Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | initiation factor 2-associated protein | 0.005 | 0.8682 | 0.773 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0038 | 0.4193 | 0.4193 |
Echinococcus granulosus | aldo keto reductase | 0.0038 | 0.4193 | 0.4193 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0038 | 0.4193 | 0.4193 |
Toxoplasma gondii | methionine aminopeptidase | 0.0054 | 1 | 1 |
Onchocerca volvulus | Methionine aminopeptidase 2 homolog | 0.005 | 0.8682 | 1 |
Echinococcus granulosus | aldo keto reductase | 0.0038 | 0.4193 | 0.4193 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0038 | 0.4193 | 0.4193 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) | 0.0036 | 0.3367 | 0.8029 |
Brugia malayi | initiation factor 2-associated protein. | 0.005 | 0.8682 | 0.773 |
Treponema pallidum | methionine aminopeptidase (map) | 0.0036 | 0.3367 | 0.5 |
Echinococcus multilocularis | aldo keto reductase | 0.0038 | 0.4193 | 0.4193 |
Mycobacterium leprae | PROBABLE OXIDOREDUCTASE | 0.0038 | 0.4193 | 1 |
Echinococcus multilocularis | methionyl aminopeptidase 1 (M24 family) | 0.0036 | 0.3367 | 0.3367 |
Leishmania major | methionine aminopeptidase 2, putative | 0.005 | 0.8682 | 0.773 |
Trypanosoma brucei | methionine aminopeptidase, type I, putative | 0.0054 | 1 | 1 |
Echinococcus multilocularis | methionyl aminopeptidase 2 | 0.005 | 0.8682 | 0.8682 |
Plasmodium vivax | methionine aminopeptidase 2, putative | 0.005 | 0.8682 | 0.8012 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.005 | 0.8682 | 1 |
Echinococcus granulosus | aldo keto reductase | 0.0038 | 0.4193 | 0.4193 |
Echinococcus multilocularis | aldo keto reductase | 0.0038 | 0.4193 | 0.4193 |
Toxoplasma gondii | methionine aminopeptidase 2, putative | 0.005 | 0.8682 | 0.8012 |
Wolbachia endosymbiont of Brugia malayi | methionine aminopeptidase | 0.0036 | 0.3367 | 0.5 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0038 | 0.4193 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0038 | 0.4193 | 0.4193 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0038 | 0.4193 | 0.4193 |
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.005 | 0.8682 | 0.773 |
Trypanosoma brucei | metallo- peptidase, Clan MG, Family M24 | 0.0054 | 1 | 1 |
Toxoplasma gondii | aldose reductase, putative | 0.0038 | 0.4193 | 0.1246 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0038 | 0.4193 | 0.4193 |
Plasmodium falciparum | methionine aminopeptidase 2 | 0.005 | 0.8682 | 0.8012 |
Echinococcus multilocularis | aldo keto reductase | 0.0038 | 0.4193 | 0.4193 |
Entamoeba histolytica | methionine aminopeptidase, putative | 0.005 | 0.8682 | 1 |
Leishmania major | methionine aminopeptidase, putative,metallo-peptidase, Clan MG, Family M24 | 0.0054 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0038 | 0.4193 | 0.4193 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0038 | 0.4193 | 0.4193 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.005 | 0.8682 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0038 | 0.4193 | 0.4193 |
Schistosoma mansoni | aldo-keto reductase | 0.0038 | 0.4193 | 0.1555 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0038 | 0.4193 | 0.4193 |
Schistosoma mansoni | methionyl aminopeptidase 2 (M24 family) | 0.005 | 0.8682 | 1 |
Trypanosoma cruzi | metallo- peptidase, Clan MG, Family M24 | 0.0054 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0038 | 0.4193 | 0.4193 |
Plasmodium vivax | methionine aminopeptidase 1b, putative | 0.0054 | 1 | 1 |
Trypanosoma cruzi | metallo- peptidase, Clan MG, Family M24 | 0.0054 | 1 | 1 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.005 | 0.8682 | 1 |
Echinococcus multilocularis | aldo keto reductase | 0.0038 | 0.4193 | 0.4193 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0038 | 0.4193 | 0.4193 |
Echinococcus granulosus | methionyl aminopeptidase 1 M24 family | 0.0054 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0038 | 0.4193 | 0.4193 |
Chlamydia trachomatis | methionine aminopeptidase | 0.0036 | 0.3367 | 0.5 |
Plasmodium falciparum | methionine aminopeptidase 1b, putative | 0.0054 | 1 | 1 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) | 0.0036 | 0.3367 | 0.8029 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0038 | 0.4193 | 0.4193 |
Echinococcus multilocularis | methionyl aminopeptidase 1 (M24 family) | 0.0054 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0038 | 0.4193 | 0.4193 |
Trypanosoma brucei | methionine aminopeptidase, putative | 0.0054 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0038 | 0.4193 | 0.4193 |
Mycobacterium ulcerans | oxidoreductase | 0.0038 | 0.4193 | 1 |
Trypanosoma brucei | metallo-peptidase, Clan MG, Family M24 | 0.005 | 0.8682 | 0.773 |
Schistosoma mansoni | pol-related | 0.0038 | 0.4193 | 0.1555 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0038 | 0.4193 | 0.4193 |
Loa Loa (eye worm) | methionine aminopeptidase type I | 0.0054 | 1 | 1 |
Trypanosoma brucei | methionine aminopeptidase 2, putative | 0.005 | 0.8682 | 0.773 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0038 | 0.4193 | 0.4193 |
Echinococcus granulosus | hypothetical protein | 0.0038 | 0.4193 | 0.4193 |
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.005 | 0.8682 | 0.773 |
Echinococcus granulosus | methionyl aminopeptidase 2 | 0.005 | 0.8682 | 0.8682 |
Schistosoma mansoni | aldo-keto reductase | 0.0038 | 0.4193 | 0.1555 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0038 | 0.4193 | 0.4193 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0038 | 0.4193 | 0.4193 |
Giardia lamblia | Methionine aminopeptidase | 0.005 | 0.8682 | 1 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.005 | 0.8682 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (binding) | = 980 uM | Inhibitory concentration of the compound against aldose reductase obtained from rat lens | ChEMBL. | 2491890 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.